GL1X · GenesisL1 explorer

Research workbench

Crystal structure of aeromonas proteolytica aminopeptidase complexed with 8-quinolinol

Analyse Crystal structure of aeromonas proteolytica aminopeptidase complexed with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VH9
Type
protein
Length
291 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bacterial leucyl aminopeptidase
EC
3.4.11.10
UniProt
Q01693
Ligands
HQY, NA, ZN, CL, SCN
Pockets
1 · best druggability 0.43

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABacterial leucyl aminopeptidase (EC 3.4.11.10)protein29141% helix, 19% strandQ01693

Ligands and binding sites

  • HQY · quinolin-8-ol · ligand · chains A
  • NA · Sodium ion · metal · 9 copies · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A
  • CL · Chloride ion · ion · 9 copies · chains A
  • SCN · Thiocyanate ion · ion · 2 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1560.430.8318HQY, NA

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 3VH9 · Crystal structure of Aeromonas proteolytica aminopeptidase complexed with 8-quinolinol · the same entry in another collection · chain A against A, TM-score 1.00
  • Q01693 · AlphaFold monomer V2.0 prediction for bacterial leucyl aminopeptidase (Q01693) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.